When to perform hepatic resection for intermediate-stage hepatocellular carcinoma

Hepatology

Volumn 61, Issue 3, 2015, Pages 905-914

  Cucchetti, Alessandro ^a   Djulbegovic, Benjamin ^b   Tsalatsanis, Athanasios ^b   Vitale, Alessandro ^c   Hozo, Iztok ^d   Piscaglia, Fabio ^a   Cescon, Matteo ^a   Ercolani, Giorgio ^a   Tuci, Francesco ^c   Cillo, Umberto ^c   Pinna, Antonio Daniele ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF PADOVA   (Italy)

^d INDIANA UNIVERSITY NORTHWEST   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMOEMBOLIZATION; CHILD PUGH SCORE; ESOPHAGUS VARICES; FEMALE; HEALTH SURVEY; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PHYSICIAN; PREDICTOR VARIABLE; PRIORITY JOURNAL; SURGEON; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; TIME;

AGED; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 84923423190     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27321     Document Type: Article

References (28)

1. El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 2012;142:1264-1273.
2. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908-943.
3. Bruix J, Sherman M; American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma: an update. Hepatology 2011;53:1020-1022.
4. Forner A, Reig ME, de Lope CR, Bruix J. Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis 2010;30:61-74.
5. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, et al. Snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 2013;257:929-937.
6. Zhong JH, Ke Y, Gong WF, Xiang BD, Ma L, Ye XP, et al. Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg 2013 Oct 3. [Epub ahead of print] PMID: 24096763.
7. Wang JH, Changchien CS, Hu TH, Lee CM, Kee KM, Lin CY, et al. The efficacy of treatment schedules according to Barcelona Clinic Liver Cancer staging for hepatocellular carcinoma-survival analysis of 3892 patients. Eur J Cancer. 2008;44:1000-1006.
8. Torzilli G, Belghiti J, Kokudo N, Takayama T, Capussotti L, Nuzzo G, et al. Reply to the letter to the editor entitled "A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West Study Group": when the study setting "ignores" the patients. Ann Surg 2013 Nov 18. [Epub ahead of print] PMID: 24253157.
9. Loomes G, Sugden R. Regret theory: an alternative theory of rational choice under uncertainty. Econ J 1982;92:805-824.
10. Smith RD. Is regret theory an alternative basis for estimating the value of healthcare interventions? Health Pol 1996;37:105-115.
11. Djulbegovic B, Hozo I, Schwartz A, McMasters KM. Acceptable regret in medical decision making. Med Hypotheses 1999;53:253-259.
12. Gilovich T, Medvec VH. The experience of regret: what, when, and why. Psychol Rev 1995;102:379-395.
13. Tsalatsanis A, Hozo I, Vickers A, Djulbegovic B. A regret theory approach to decision curve analysis: a novel method for eliciting decision makers' preferences and decision-making. BMC Med Inform Decis Mak 2010;10:51.
14. Tsalatsanis A, Barnes LE, Hozo I, Djulbegovic B. Extensions to regret-based decision curve analysis: an application to hospice referral for terminal patients. BMC Med Inform Decis Mak 2011;11:7.
15. Hernandez JM, Tsalatsanis A, Humphries LA, Miladinovic B, Djulbegovic B, Velanovich V. Defining optimum treatment of patients with pancreatic adenocarcinoma using regret-based decision curve analysis. Ann Surg 2013 Oct 28. [Epub ahead of print] PMID: 24169177.
16. Pauker SG, Kassirer JP. Therapeutic decision making: a cost-benefit analysis. N Engl J Med 1975;293:229-234.
17. Pauker SG, Kassirer JP. The threshold approach to clinical decision making. N Engl J Med 1980;302:1109-1117.
18. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-574.
19. Cillo U, Vitale A, Grigoletto F, Farinati F, Brolese A, Zanus G, et al. Prospective validation of the Barcelona Clinic Liver Cancer staging system. J Hepatol 2006;44:723-731.
20. Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Terzi E, Bolondi L, et al. Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Clin Cancer Res 2012;18:4397-4405.
21. Bolondi L, Burroughs A, Dufour JF, Galle PR, Mazzaferro V, Piscaglia F, et al. Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 2012;32:348-359.
22. Djulbegovic B, Hozo I. When should potentially false research findings be considered acceptable? PLoS Med 2007;4:e26.
23. Aronson E, Wilson TD, Akert RM. Social Psycology, 3rd ed. New York: Longman; 1999.
24. Italian Association for the Study of the Liver (AISF); AISF Expert Panel; AISF Coordinating Committee. Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. Dig Liver Dis 2013;45:712-723.
25. Hsu CY, Hsia CY, Huang YH, Su CW, Lin HC, Pai JT, et al. Comparison of surgical resection and transarterial chemoembolization for hepatocellular carcinoma beyond the Milan criteria: a propensity score analysis. Ann Surg Oncol 2012;19:842-849.
26. Kahneman D. Maps of bounded rationality: psychology for behavioral economics. Am Econ Rev 2003;93:1449-1475.
27. Zeelenberg M, Pieters R. A theory of regret regulation 1.1. J Consumer Psychol 2007;17:29-35.
28. Slovic P, Finucane ML, Peters E, MacGregor DG. Risk as analysis and risk as feelings: some thoughts about affect, reason, risk, and rationality. Risk Anal 2004;24:311-322.